Mandate

Vinge advises Lantbrukarnas Ekonomi-Aktiebolag in connection with the sale of LRF Konsult AB

March 13, 2018 Employment and Benefits

Vinge has advised Lantbrukarnas Ekonomi-Aktiebolag in connection with the sale of a majority of its consultancy operations in LRF Konsult AB.

LRF Konsult has 75 000 small enterprisers as customers and 130 offices all around the country, and had most recently a turnover of approximately SEK 1 billion. Lantbrukarnas Ekonomi-Aktiebolag will continue to be a minority owner and will hold approximately one fourth of the shares. The acquisition is conditional upon approval by the Swedish Competition Authority.

Vinge’s team consisted primarily of responsible partner Christina Kokko as well as partners Eva Fredrikson and Carl Johan af Petersens as well as associates Alex Miler, Marith Welin-Berger, Malin Malm Waerme and Christoffer Nordin.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025